Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Vaccine

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0264-410X(95)92777-YPMID 8578816
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antibody response to the M2 protein of influenza A virus expressed in insect cells.

  1993cited by this paper
• Production of the M2 protein of influenza A virus in insect cells is enhanced in the presence of amantadine.

  1993cited by this paper
• Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase.

  1993cited by this paper
• Influenza virus M2 protein has ion channel activity.

  1992cited by this paper
• Baculovirus expression of the glycoprotein gene of Lassa virus and characterization of the recombinant protein.

  1992cited by this paper
• Structural characteristics of the M2 protein of influenza a viruses: Evidence that it forms a tetrameric channe

  1991cited by this paper
• Evolutionary analysis of the influenza A virus M gene with comparison of the M1 and M2 proteins

  1991cited by this paper
• Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice

  1990cited by this paper
• Comparison of inactivated, live and recombinant DNA vaccines against influenza virus in a mouse model.

  1990cited by this paper
• Structural basis of immune recognition of influenza virus hemagglutinin.

  1990cited by this paper
• Mechanism of immunity to influenza: maternal and passive neonatal protection following immunization of adult ferrets with a live vaccinia-influenza virus haemagglutinin recombinant but not with recombinants containing other influenza virus proteins.

  1989cited by this paper
• Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions

  1988cited by this paper
• Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes

  1987cited by this paper
• Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface.

  1985cited by this paper
• Effects of Low- and High-Passage Influenza Virus Infection in Normal and Nude Mice

  1977cited by this paper

• An effective vaccine against influenza A virus based on the matrix protein 2 (M2)

  2024cites this paper
• Immunogenicity and effectiveness of a bivalent influenza A/H1N2 vaccine strain against seasonal human influenza A viruses in mice

  2022cites this paper
• Strategy construction to minimize the limitation of respiratory viral vaccine development

  2022cites this paper
• An inactivated multivalent influenza A virus vaccine is broadly protective in mice and ferrets

  2021cites this paper
• Elicitation of Highly Pathogenic Avian Influenza H5N1 M2e and HA2-Specific Humoral and Cell-Mediated Immune Response in Chicken Following Immunization With Recombinant M2e–HA2 Fusion Protein

  2021cites this paper
• Design and Computational Analysis of a Chimeric Avian Influenza Antigen: A Yeast-displayed, Universal and Cross-protective Vaccine Candidate

  2021cites this paper
• Combination of conserved recombinant proteins (NP & 3M2e) formulated with Alum protected BALB/c mice against influenza A/PR8/H1N1 virus challenge

  2021cites this paper
• Engineered Nanoparticle Applications for Recombinant Influenza Vaccines.

  2020cites this paper
• mRNA Encoding a Bispecific Single Domain Antibody Construct Protects against Influenza A Virus Infection in Mice

  2020cites this paper
• Influenza Chimeric Protein (3M2e-3HA2-NP) Adjuvanted with PGA/Alum Confers Cross-Protection against Heterologous Influenza A Viruses

  2020cites this paper
• Influenza A Virus in Swine: Epidemiology, Challenges and Vaccination Strategies

  2020cites this paper
• Vaccines from the Spanish Influenza as a firm foundation for new developments

  2020cites this paper
• Selective Engagement of FcγRIV by a M2e-Specific Single Domain Antibody Construct Protects Against Influenza A Virus Infection

  2019cites this paper
• The Role of Matrix Protein 2 Ectodomain in the Development of Universal Influenza Vaccines

  2019cites this paper
• Unanswered questions about the 1918 influenza pandemic: origin, pathology, and the virus itself.

  2018cites this paper
• Flagellin as a vaccine adjuvant

  2018cites this paper
• Efficient and Stable Delivery of Multiple Genes to Fish Cells by a Modified Recombinant Baculovirus System

  2018cites this paper
• How far have we reached in development of effective influenza vaccine?

  2018cites this paper
• VIRUS-BASED VLPS FREE OF INFECTIOUS AGENTS

  2017cites this paper
• Monomeric M2e antigen in VesiVax® liposomes stimulates protection against type a strains of influenza comparable to liposomes with multimeric forms of M2e

  2017cites this paper
• Surveillance Study of Influenza Occurrence and Immunity in a Wisconsin Cohort During the 2009 Pandemic

  2017cites this paper
• Expression and purification of native and functional influenza A virus matrix 2 proton selective ion channel.

  2017cites this paper
• Vaccine approaches conferring cross-protection against influenza viruses

  2017cites this paper
• Establishment of memory CD 8 + T cells with live attenuated influenza 2 virus ( LAIV ) across different vaccination doses

  2016cites this paper
• Attenuated Strains of Salmonella enterica Serovars Typhi and Paratyphi as Live Oral Vaccines Against Enteric Fever

  2016cites this paper
• Construction of chimeric protein 3M2e.FliC and its immunoinformatics analyses and expression in Bacillus subtilis

  2016cites this paper
• Development of universal Influenza vaccine in chicken with insights on the extracellular domain of Matrix protein 2

  2016influential citation
• Conserved hemagglutinin peptides of influenza virus as potential multivalent vaccine candidate: characterization of immune response in different animal models

  2016cites this paper
• Analysis of Influenza A/Beijing/353/89 Virus Matrix Gene Sequence and Identification of Replaceable Amino Acids as Natural Mutations in M2 Protein

  2016cites this paper
• Vaccines and vaccination for swine influenza: differing situations in Europe and the USA

  2016cites this paper
• Vaccine‐Induced Antibody Responses Prevent the Induction of Interferon Type I Responses Upon a Homotypic Live Virus Challenge

  2016cites this paper
• Combined local and systemic immunization is essential for durable T-cell mediated heterosubtypic immunity against influenza A virus

  2016cites this paper
• Epitomics: IgG-epitome decoding of E6, E7 and L1 proteins from oncogenic human papillomavirus type 58

  2016cites this paper
• Establishment of memory CD8+ T cells with live attenuated influenza virus across different vaccination doses.

  2016cites this paper
• A lipidated form of the extracellular domain of influenza M2 protein as a self-adjuvanting vaccine candidate.

  2015cites this paper
• Immunologic Evaluation of DNA Vaccine Encoding Influenza Virus M2 Gene in Type A- Influenza Mice Model

  2015cites this paper
• Protective Efficacy of the Conserved NP, PB1, and M1 Proteins as Immunogens in DNA- and Vaccinia Virus-Based Universal Influenza A Virus Vaccines in Mice

  2015cites this paper
• Viral adaptation to host species: assessing sequence variability in the genome of host adapted avian influenza viruses of a common origin

  2015cites this paper
• Efficacy and safety of treatment with an anti-m2e monoclonal antibody in experimental human influenza.

  2015cites this paper
• Development and Evaluation of PLGA-Nanoparticle Entrapped Influenza Virus Peptides Vaccine and Effect on Molecular Phenotype of Alveolar Macrophages with reference to DAP12 Signaling Pathway in Pigs

  2015cites this paper
• Mechanisms of cross-protection and development of universal influenza vaccines

  2015cites this paper
• An Intranasal Virus-Like Particle Vaccine Broadly Protects Mice from Multiple Subtypes of Influenza A Virus

  2015cites this paper
• The use of nonhuman primates in research on seasonal, pandemic and avian influenza, 1893-2014.

  2015cites this paper
• A broad protection provided by matrix protein 2 (M2) of avian influenza virus.

  2015cites this paper
• Intranasal Adenovirus-Vectored Vaccine for Induction of Long-Lasting Humoral Immunity-Mediated Broad Protection against Influenza in Mice

  2014cites this paper
• In Vitro Evaluation of Influenza M2 and Leishmania major HSP70 (221-604) Chimer Protein

  2014cites this paper
• Heterosubtypic protective immunity against widely divergent influenza subtypes induced by fusion protein 4sM2 in BALB/c mice

  2014cites this paper
• Lentiviral vector vaccines for T cell-mediated protection against influenza

  2014cites this paper
• MVA Vectors Expressing Conserved Influenza Proteins Protect Mice against Lethal Challenge with H5N1, H9N2 and H7N1 Viruses

  2014cites this paper
• Vaccination with recombinant 4 × M2e.HSP70c fusion protein as a universal vaccine candidate enhances both humoral and cell-mediated immune responses and decreases viral shedding against experimental challenge of H9N2 influenza in chickens.

  2014cites this paper
• Advances in influenza vaccination

  2014cites this paper
• Construction of Recombinant Bacmid Containing M2e-Ctxb and Producing the Fusion Protein in Insect Cell Lines

  2014cites this paper
• Development of universal influenza vaccines based on influenza virus M and NP genes

  2014cites this paper
• Immune responses to oral and IM administration of M2e-Hsp70 construct

  2014cites this paper
• Different Arms of the Adaptive Immune System Induced by a Combination Vaccine Work in Concert to Provide Enhanced Clearance of Influenza

  2014cites this paper
• A universal flu vaccine.

  2014cites this paper
• Vaccination induced antibodies to recombinant avian influenza A virus M2 protein or synthetic M2e peptide do not bind to the M2 protein on the virus or virus infected cells

  2013cites this paper
• Cross-protective immunity against influenza A/H1N1 virus challenge in mice immunized with recombinant vaccine expressing HA gene of influenza A/H5N1 virus

  2013cites this paper
• Traditional and New Influenza Vaccines

  2013cites this paper
• Prokaryote-expressed M2e protein improves H9N2 influenza vaccine efficacy and protection against lethal influenza a virus in mice

  2013cites this paper
• An M2e-based synthetic peptide vaccine for influenza A virus confers heterosubtypic protection from lethal virus challenge

  2013cites this paper
• H5N1 vaccines in humans.

  2013cites this paper
• New vaccines against influenza virus

  2013cites this paper
• Immunogenicity and protective efficacy of candidate universal influenza A nanovaccines produced in plants by Tobacco mosaic virus-based vectors.

  2013cites this paper
• Survey of Human Antibody Responses to Influenza Virus Matrix Protein 2 by Use of a Sensitive Flow Cytometric Method

  2013cites this paper
• Safety and tolerability of a 2009 trivalent inactivated split‐virion influenza vaccine in infants, children and adolescents

  2013cites this paper
• DNA-Vaccine Platform Development Against H1N1 Subtype of Swine Influenza A Viruses

  2012cites this paper
• A mechanistic analysis of DNA vaccine-induced tumor immunity against the viral oncoprotein simian virus 40 large tumor antigen

  2012cites this paper
• Virus-like particles as universal influenza vaccines

  2012cites this paper
• Advances in the development of universal influenza vaccines

  2012cites this paper
• Cutting Edge Approaches Toward Novel and Cross-Protective Influenza Vaccines

  2012cites this paper
• In contrast to conventional inactivated influenza vaccines, 4xM2e.HSP70c fusion protein fully protected mice against lethal dose of H1, H3 and H9 influenza A isolates circulating in Iran.

  2012cites this paper
• Evolving Strategies for the Prevention of Influenza Infection

  2012cites this paper
• Universal vaccine against influenza virus: Linking TLR signaling to anti‐viral protection

  2012cites this paper
• Exploiting the matrix protein 2 for protection against influenza virus infection

  2012cites this paper
• Universal protein vaccines against Neisseria meningitidis serogroup B, Streptococcus pneumoniae and influenza

  2011cites this paper
• Novel vaccines against influenza viruses.

  2011cites this paper
• A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza.

  2011cites this paper
• Characterization of the murine Th2 response to immunization with liposomal M2e influenza vaccine.

  2011cites this paper
• Vaccine production, distribution, access, and uptake.

  2011cites this paper
• New Decade of Vaccines 3 Vaccine production, distribution, access, and uptake

  2011cites this paper
• Immunity to Influenza and Future Vaccination Strategies

  2011cites this paper
• Cold-Adapted Influenza and Recombinant Adenovirus Vaccines Induce Cross-Protective Immunity against pH1N1 Challenge in Mice

  2011cites this paper
• Influenza A viruses: why focusing on M2e-based universal vaccines

  2011cites this paper
• Evaluation of anti-influenza efficiency of polyclonal IgG antibodies specific to the ectodomain of M2 protein of influenza A virus by passive immunization of mice.

  2011cites this paper
• Cross-protective immunity against influenza pH1N1 2009 viruses induced by seasonal influenza A (H3N2) virus is mediated by virus-specific T-cells.

  2011cites this paper
• Sublingual Immunization with M2-Based Vaccine Induces Broad Protective Immunity against Influenza

  2011cites this paper
• A novel non-toxic combined CTA1-DD and ISCOMS adjuvant vector for effective mucosal immunization against influenza virus.

  2011cites this paper
• Potent Neutralization of Influenza A Virus by a Single-Domain Antibody Blocking M2 Ion Channel Protein

  2011cites this paper
• Induction of Virus-Specific Cytotoxic T Lymphocytes as a Basis for the Development of Broadly Protective Influenza Vaccines

  2011cites this paper
• A Novel Vaccine Using Nanoparticle Platform to Present Immunogenic M2e against Avian Influenza Infection

  2011cites this paper
• Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults.

  2011cites this paper
• Avian Influenza Adenovirus-Vectored in Ovo Vaccination: Combination with Marek's Disease Vaccine

  2011cites this paper
• Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant

  2010cites this paper
• Targets for the Induction of Protective Immunity Against Influenza A Viruses

  2010cites this paper
• Prokaryotic expression and characterization of avian influenza A virus M2 gene as a candidate for universal recombinant vaccine against influenza A subtypes; specially H5N1 and H9N2

  2010cites this paper
• An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses

  2010cites this paper
• Delivery of woodchuck hepatitis virus-like particle presented influenza M2e by recombinant attenuated Salmonella displaying a delayed lysis phenotype.

  2010cites this paper
• Development and evaluation of DNA vaccines in chickens against a wild bird H6N2 avian influenza virus from Western Australia

  2010cites this paper
• Antibody Contributes to Heterosubtypic Immunity In the Cotton Rat Model of Influenza

  2010cites this paper